GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » United Laboratories International Holdings Ltd (OTCPK:ULIHF) » Definitions » Net Change in Cash

ULIHF (United Laboratories International Holdings) Net Change in Cash : $285 Mil (TTM As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is United Laboratories International Holdings Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

United Laboratories International Holdings's Net Change in Cash for the six months ended in Dec. 2024 was $-31 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was $285 Mil.

United Laboratories International Holdings Net Change in Cash Historical Data

The historical data trend for United Laboratories International Holdings's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Laboratories International Holdings Net Change in Cash Chart

United Laboratories International Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only -25.69 52.47 202.54 -67.38 284.02

United Laboratories International Holdings Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 101.14 0.25 -67.63 316.05 -30.90

United Laboratories International Holdings Net Change in Cash Calculation

United Laboratories International Holdings's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=439.422+-237.352+81.985+-0.037
=284

United Laboratories International Holdings's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=185.933+-165.427+-51.295+-0.114
=-31

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $285 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

United Laboratories International Holdings Net Change in Cash Related Terms

Thank you for viewing the detailed overview of United Laboratories International Holdings's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

United Laboratories International Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » United Laboratories International Holdings Ltd (OTCPK:ULIHF) » Definitions » Net Change in Cash
Comparable Companies
HKSE:02096 HKSE:00867 HKSE:00512 HKSE:03320 HKSE:06185 HKSE:01558 HKSE:00570 HKSE:02005 HKSE:01681 HKSE:02186 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
03933:Hong Kong UNJ:Germany
Address
No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG
Website
http://www.tul.com.cn
United Laboratories International Holdings Ltd is a drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. Majority of the company's sales are generated in China, followed by Europe, India and other countries.

United Laboratories International Holdings Headlines

No Headlines